‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon
Heard of collateral lethality? It’s a therapeutic strategy that uses gene deletions with no direct role in the tumor progression. A recent... Read More
miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression
New Plos Onestudy shows miR-1296-5p may be a tumor suppressor of the miRNA molecule in gastric cancer as well as a clinical... Read More
